Member Info for itsallamess

https://twitter.com/stocks_and/status/1200482943388585984?s=19

https://twitter.com/iancassel/status/1200393346910498816?s=19

Feels like they are holding the SP while they fill a very large order...

If I was a II I would be buying FARN now

3rd December Finns start buying but 30 minutes before bell rings a RNS drops with FDA approval to fast track Traukamine

Where will the SP then?

I read from this that you can have phase 3 trials which are designed to prove 100% if a drug works or not.. but if you are granted 'breakthrough status' in the USA and 'Prime status' in the EU they are giving permission to give the drug to end of life patients... and as we have seen it has already worked on ones who have had 6 different failed treatments

1. If you get to trial this then it could mean you've gained your life back
2. In itself it's like a mini phase 3 trail and good results will mean fast tracking clevegen
3.the SP will reflect this

Thanks CB

And prime status:

"Eligibility criteria. The scheme focuses on medicines that may offer a major therapeutic advantage over existing treatments, or benefit patients without treatment options. ... To be accepted for PRIME, a medicine has to show its potential to benefit patients with unmet medical needs based on early clinical data"

Been busy all day, just digesting the monumental RNS... this stood out to me:

"With the US IND now approved, in due course, we plan to file applications for Breakthrough status in the US and Prime status in Europe, further facilitating regulatory interactions during the development of Clevegen."

Googled breakthough status;

"The FDA designed its Breakthrough Therapy status to give drugs intended to treat serious conditions a head start when they demonstrate a “substantial improvement” over medical solutions already available on the market"

https://www.proactiveinvestors.co.uk/companies/news/908060/faron-pharmaceuticals-shares-up-45-after-us-regulatory-green-light-for-cancer-immunotherapy-908060.html

Nice article.. couldn't help but notice a reference to "partners"

Got alot on this week so a bit preoccupied...

Everything coming on well...

By 3rd Decembermbervtge finns will be paying premium price to get in which will send the SP higher

Dont forget this;

"Markku Jalkanen, CEO of Faron Pharmaceuticals said: “TAMs have been recognised by scientists for years as a key control element in cancer immune biology. The recent licensing deal for up to $1.74 billion between Five Prime and Bristol-Myers Squibb, which included an upfront payment of $350 million for a Phase I trial in immuno-oncology, demonstrates the commercial potential to Faron for the successful development and commercialisation of Clevegen"

Looking strong!

Drac, I've just reported him

Early December we meet with the FDA for Traumakine relaunch just in time for the Finnish market to easily buy shares

Markku knows the SP will explode and he is giving his countrymen a few says to load up

Looks like the listing will go ahead

I expect we will be added to this page soon
http://www.nasdaqomxnordic.com/news/listings/firstnorth/2019

Wouldn't surprise me if Timo stats nabbing shares from this exchange

He may well have 20% in his sights

Busy week for me this week so not around much for the crack

Well spotted zen
"Sisu Partners Oy, Certified Adviser on Nasdaq First North
Juha Karttunen, Jussi Majamaa

Distribution:
Nasdaq Helsinki Ltd"

Looked back at some previous RNS... this new info was also on the rns which proposed the dual listing

The sells aren't for massive amounts.

Looks like day traders who bought in thinking this would you up and down are selling to get their money back.

Good riddance to them!

I tell you who isn't selling... timo and Ffarons directors.. rather they keep buying more..

So who do you follow.. the daytraders who are inpatient or the ones who acually work at faron pharmaceuticals and buy more or hold ?

http://www.nasdaqomxnordic.com/news/listings/firstnorth/2019

We should be found here soon!

The article says 1st dec to start trading

Basically you will see an influx of buys on that day equals SP rise!

https://www.proactiveinvestors.co.uk/companies/news/907530/faron-pharmaceuticals-applies-to-list-shares-on-nasdaq-first-north-growth-market-907530.html

Its possible that the nordic II coming onboard wanted a listing on the nordic stock exchange to trade their share they just bought for sometime in the future to the scandinavians... keep the shares in the family so to speak...

Also the BOD knowing that the company is about to go global may well also want their own Scandinavians to benefit